Month: October 2022

Brown, Ryan K.; Hooper, Thomas N.; Rekhroukh, Feriel; White, Andrew J. P.; Costa, Paulo J.; Crimmin, Mark R. published an article in 2021, the title of the article was Alumination of aryl methyl ethers: switching between sp2 and sp3 C-O bond functionalisation with Pd-catalysis.Name: 1,2-Dimethoxybenzene And the article contains the following content:

The reaction of aluminum(I) β-diketiminate [(ArN:CMeCHCMe:NAr)Al] (Ar = 2,6-iPr2C6H3) with aryl Me ethers proceeded with alumination of the sp3 C-O bond. The selectivity of this reaction could be switched by inclusion of a catalyst. In the presence of [Pd(PCy3)2], chemoselective sp2 C-O bond functionalization was observed Kinetic isotope experiments and DFT calculations support a catalytic pathway involving the ligand-assisted oxidative addition of the sp2 C-O bond to a Pd-Al intermetallic complex. The experimental process involved the reaction of 1,2-Dimethoxybenzene(cas: 91-16-7).Name: 1,2-Dimethoxybenzene

The Article related to aluminum subvalent diketiminate oxidative addition phenol benzyl ether, carbon oxygen bond chemoselective activation phenyl benzyl ether, organoaluminum diketiminate preparation oxidative addition aryl benzyl alkyl ether, crystal mol structure aluminum alkoxide diketiminate aryl complex and other aspects.Name: 1,2-Dimethoxybenzene

Referemce:
Ether – Wikipedia,
Ether | (C2H5)2O – PubChem

On September 17, 2001, Stavenger, Robert A.; Schreiber, Stuart L. published an article.SDS of cas: 929-37-3 The title of the article was Asymmetric catalysis in diversity-oriented organic synthesis: Enantioselective synthesis of 4320 encoded and spatially segregated dihydropyrancarboxamides. And the article contained the following:

Dihydropyrancarboxylates were prepared on solid-phase by stereoselective and enantioselective hetero Diels-Alder cycloaddition of β,γ-unsaturated-α-keto esters to resin-bound vinyl ethers in the presence of nonracemic copper bis(oxazoline) catalysts as intermediates in the preparation of an encoded combinatorial library of dihydropyrancarboxamides. Hydroxy-substituted vinyl ethers were prepared; the vinyl ethers were attached by treatment of silyl-substituted polystyrene resin macrobeads with triflic acid followed by addition of the hydroxy-substituted vinyl ethers to the resin-bound silyl triflate; the resin-bound vinyl ethers were treated with chloroarom. diazoketones in the presence of dirhodium tetraacetate to give tagged resin-bound vinyl ethers which could be later identified by LC-MS. Treatment of resin-bound vinyl ethers such as I with the heterodienes (E)-RCH:CHCOCO2CH2CH:CH2 (R = Me2CH, Ph, 2-fluorenyl, 4-MeO2CC6H4, 5-benzo-1,3-dioxolanyl, 3-thienyl, 3-benzofuranyl, 1-acetyl-3-indolyl, 4-oxo-3-benzopyranyl, 1,5-dimethyl-3-oxo-2-phenyl-2,3-dihydropyrazolyl) in the presence of the bis(oxazoline) II (or its enantiomer) and copper (II) triflate followed by cleavage of the resin with HF•pyridine gives nonracemic dihydropyrancarboxylates such as III (or their enantiomers) in >5:1 diastereoselectivities and >30:1 enantioselectivities. The resin-bound dihydropyrancarboxylates could be tagged with a second chloroarom. diazoketone, deallylated with tetrakis(triphenylphosphine)palladium and thiosalicylic acid in THF, coupled with primary and secondary amines with the benzotriazolyloxyphosphonium salt PyBOP and diisopropylethylamine, and cleaved from the resin with HF•pyridine to give an encoded combinatorial library of natural product-like nonracemic dihydropyrancarboxamides (no data). E.g., treatment of the silyl-substituted polystyrene resin with triflic acid followed by the addition of sulfonamide-substituted vinyl ether I with lutidine gave a resin-bound vinyl ether; the vinyl ether resin was added to unsaturated ketoester (E)-Me2CHCH:CHCOCO2CH2CH:CH2 and mol. sieves under argon; addition of THF and a solution of II and copper triflate in THF and stirring gave a resin-bound nonracemic dihydropyrancarboxylate which was cleaved from the resin with HF•pyridine to give III in >95% purity and in >16:1 diastereo- and enantioselectivities. Cleavage of a subset of the dihydropyrancarboxamide-containing beads and anal. by LC-MS indicated that 104 of the 108 sample compounds were isolated in >75% purity. The use of asym. synthesis of natural product-like libraries on encoded beads allows for the use of stereochem. as a diversity element in the preparation of combinatorial libraries; the prepared libraries are produced in a form amenable to robot-controlled biol. testing. The experimental process involved the reaction of 2-(2-(Vinyloxy)ethoxy)ethanol(cas: 929-37-3).SDS of cas: 929-37-3

The Article related to dihydropyrancarboxylate stereoselective enantioselective preparation intermediate combinatorial library, dihydropyrancarboxamide stereoselective enantioselective preparation combinatorial library, copper bisoxazoline catalyst enantioselective cycloaddition unsaturated ketoester vinyl ether and other aspects.SDS of cas: 929-37-3

Referemce:
Ether – Wikipedia,
Ether | (C2H5)2O – PubChem

On February 19, 2021, Zhao, Lanxiao; Shi, Xianghui; Cheng, Jianhua published an article.Recommanded Product: 150-78-7 The title of the article was Calcium-Catalyzed Dehydrogenative Silylation of Aromatic Ethers with Hydrosilane. And the article contained the following:

The catalytic regioselective C-H silylation of a wide range of alkoxy-substituted benzene derivatives with primary hydrosilane was achieved using scorpionate-supported Ca benzyl complex [(TpAd,iPr)Ca(p-CH2C6H4Me)(THP)] (1) (TpAd,iPr = hydrotris(3-adamantyl-5-isopropylpyrazolyl)borate, THP = tetrahydropyran) as the precatalyst. This protocol offers an atom-efficient and straightforward method for the synthesis of a variety of silyl-substituted aromatic ether derivatives without a H acceptor and free of transition metal. Ca anisyl complexes [(TpAd,iPr)Ca(o-MeO-m-Br-C6H3)] (5) and [(TpAd,iPr)Ca(o-Me-OCH2C6H4)] (6), proposed as the catalytic reaction intermediates, were isolated and structurally characterized. The experimental process involved the reaction of 1,4-Dimethoxybenzene(cas: 150-78-7).Recommanded Product: 150-78-7

The Article related to calcium benzyl complex catalyzed dehydrogenative silylation aromatic ether hydrosilane, scorpionate supported calcium benzyl ether complex preparation crystal structure, mol structure scorpionate supported calcium benzyl ether complex, silyl substituted aromatic ether derivative preparation and other aspects.Recommanded Product: 150-78-7

Referemce:
Ether – Wikipedia,
Ether | (C2H5)2O – PubChem

On February 19, 2021, Zhao, Lanxiao; Shi, Xianghui; Cheng, Jianhua published an article.Application of 578-58-5 The title of the article was Calcium-Catalyzed Dehydrogenative Silylation of Aromatic Ethers with Hydrosilane. And the article contained the following:

The catalytic regioselective C-H silylation of a wide range of alkoxy-substituted benzene derivatives with primary hydrosilane was achieved using scorpionate-supported Ca benzyl complex [(TpAd,iPr)Ca(p-CH2C6H4Me)(THP)] (1) (TpAd,iPr = hydrotris(3-adamantyl-5-isopropylpyrazolyl)borate, THP = tetrahydropyran) as the precatalyst. This protocol offers an atom-efficient and straightforward method for the synthesis of a variety of silyl-substituted aromatic ether derivatives without a H acceptor and free of transition metal. Ca anisyl complexes [(TpAd,iPr)Ca(o-MeO-m-Br-C6H3)] (5) and [(TpAd,iPr)Ca(o-Me-OCH2C6H4)] (6), proposed as the catalytic reaction intermediates, were isolated and structurally characterized. The experimental process involved the reaction of 2-Methylanisole(cas: 578-58-5).Application of 578-58-5

The Article related to calcium benzyl complex catalyzed dehydrogenative silylation aromatic ether hydrosilane, scorpionate supported calcium benzyl ether complex preparation crystal structure, mol structure scorpionate supported calcium benzyl ether complex, silyl substituted aromatic ether derivative preparation and other aspects.Application of 578-58-5

Referemce:
Ether – Wikipedia,
Ether | (C2H5)2O – PubChem

On February 19, 2021, Zhao, Lanxiao; Shi, Xianghui; Cheng, Jianhua published an article.Name: 2-Methoxynaphthalene The title of the article was Calcium-Catalyzed Dehydrogenative Silylation of Aromatic Ethers with Hydrosilane. And the article contained the following:

The catalytic regioselective C-H silylation of a wide range of alkoxy-substituted benzene derivatives with primary hydrosilane was achieved using scorpionate-supported Ca benzyl complex [(TpAd,iPr)Ca(p-CH2C6H4Me)(THP)] (1) (TpAd,iPr = hydrotris(3-adamantyl-5-isopropylpyrazolyl)borate, THP = tetrahydropyran) as the precatalyst. This protocol offers an atom-efficient and straightforward method for the synthesis of a variety of silyl-substituted aromatic ether derivatives without a H acceptor and free of transition metal. Ca anisyl complexes [(TpAd,iPr)Ca(o-MeO-m-Br-C6H3)] (5) and [(TpAd,iPr)Ca(o-Me-OCH2C6H4)] (6), proposed as the catalytic reaction intermediates, were isolated and structurally characterized. The experimental process involved the reaction of 2-Methoxynaphthalene(cas: 93-04-9).Name: 2-Methoxynaphthalene

The Article related to calcium benzyl complex catalyzed dehydrogenative silylation aromatic ether hydrosilane, scorpionate supported calcium benzyl ether complex preparation crystal structure, mol structure scorpionate supported calcium benzyl ether complex, silyl substituted aromatic ether derivative preparation and other aspects.Name: 2-Methoxynaphthalene

Referemce:
Ether – Wikipedia,
Ether | (C2H5)2O – PubChem

On November 30, 2021, Zhang, Ying-Qi; Chen, Yang-Bo; Liu, Ji-Ren; Wu, Shao-Qi; Fan, Xin-Yang; Zhang, Zhi-Xin; Hong, Xin; Ye, Long-Wu published an article.Reference of 2-Methoxynaphthalene The title of the article was Asymmetric dearomatization catalysed by chiral Bronsted acids via activation of ynamides. And the article contained the following:

The chiral Bronsted acids enable the catalytic asym. dearomatization reactions of naphthols- phenols- RCCN(R1)R2 (R = 2-(4-hydroxynaphthalen-1-yl)benzen-1-yl, 2-(4-hydroxy-1,4,5,6,7,8-hexahydronaphthalen-1-yl)benzen-1-yl, 2-(2-hydroxyphenyl)benzen-1-yl, etc.; R1 = Ms, Ts, Bs, etc.; R2 = Ph, naphthalen-2-yl, n-Bu, etc.) and pyrrole-ynamides R3(CH2)2NCC(R1)R2 (R3 = 2,5-dimethyl-1H-pyrrol-1-yl, 2-methyl-5-(thiophen-3-yl)-1H-pyrrol-1-yl, 2-methyl-5-phenyl-1H-pyrrol-1-yl, etc.) by the direct activation of alkynes. This method leads to the practical and atom-economic construction of various valuable spirocyclic enones I (R4 = H, 6-F, benzene-1,2-bis(yl), 5-Cl, etc.) and II, 2H-pyrroles III (R5 = Me, Ph, thiophen-2-yl, etc.; R6 = Me, Et) that bear a chiral quaternary carbon stereocenter in generally good-to-excellent yields with excellent chemo-, regio- and enantioselectivities. The activation mode of chiral Bronsted acid catalysis revealed in this study is expected to be of broad utility in catalytic asym. reactions that involve ynamides and the related heteroatom-substituted alkynes. The experimental process involved the reaction of 2-Methoxynaphthalene(cas: 93-04-9).Reference of 2-Methoxynaphthalene

The Article related to spirocyclic enone preparation regioselective chemoselective diastereoselective, naphthol ynamide preparation asym dearomatization bronsted acid catalyst, phenol ynamide preparation asym dearomatization bronsted acid catalyst, pyrrole preparation regioselective chemoselective diastereoselective and other aspects.Reference of 2-Methoxynaphthalene

Referemce:
Ether – Wikipedia,
Ether | (C2H5)2O – PubChem

On November 4, 2016, Lansakara, Ashabha I.; Mariappan, S. V. Santhana; Pigge, F. Christopher published an article.Synthetic Route of 929-37-3 The title of the article was Alkylidene Dihydropyridines As Synthetic Intermediates: Model Studies toward the Synthesis of the Bis(piperidine) Alkaloid Xestoproxamine C. And the article contained the following:

Results of model studies demonstrating a stereoselective synthetic route to tricyclic analogs of the bis(piperidine) alkaloid xestoproxamine C are presented. Dearomatization of a tricyclic pyridine derivative to afford an alkylidene dihydropyridine (anhydrobase) intermediate followed by catalytic heterogeneous hydrogenation was used to install the correct relative stereochem. about the bis(piperidine) ring system. Other key features of these model studies include development of an efficient ring-closing metathesis procedure to prepare macrocyclic derivatives of 3,4-disubstituted pyridines, intramol. cyclizations of alkylidene dihydropyridines to establish pyridine-substituted pyrrolidines and piperidines, successful homologation of pyridine-4-carboxaldehydes using formaldehyde di-Me thioacetal monoxide (FAMSO), and application of B-alkyl Suzuki coupling to assemble substituted pyridines. The experimental process involved the reaction of 2-(2-(Vinyloxy)ethoxy)ethanol(cas: 929-37-3).Synthetic Route of 929-37-3

The Article related to xestoproxamine c analog stereoselective synthesis alkylidenedihydropyridine intermediate model study, dearomatization tricyclic pyridine derivative alkylidenedihydropyridine, stereoselective hydrogenation alkylidenedihydropyridine, ring closing macrocyclization xestoproxamine c analog synthesis and other aspects.Synthetic Route of 929-37-3

Referemce:
Ether – Wikipedia,
Ether | (C2H5)2O – PubChem

On May 29, 1991, Dubroeucq, Marie Christine; Moutonnier, Claude; Peyronel, Jean Francois; Tabart, Michel; Truchon, Alain published a patent.Application In Synthesis of (S)-2-(2-Methoxyphenyl)propanoic acid The title of the patent was Preparation of 2-(phenylacetyl)-7,7-diphenylperhydroisoindol-4-ones and analogs as substance P antagonists. And the patent contained the following:

Title compounds [I; R = H; RR = bond; R4 = Ph, halophenyl, tolyl; R5 = C(:X)CHR1R2; R1 = (un)substituted Ph, alkyl, alkoxy, etc.; R2 = H, halo, OH, alkyl, etc.; X = O, S, NR3; R3 = H, dialkylamino, (un)substituted alkyl] were prepared Thus, 4,4-diphenyl-2-cyclohexenone was cyclocondensed with PhCH2N(CH2OBu)CH2SiMe3 to give, after debenzylation and optical resolution, (3aR, 7aR)-I (R = H, R4 = Ph) (II; R5 = H) which was condensed with 2-(Me2N)C6H4CH2CO2H to give II [R5 = COCH2C6H4(NMe2)-2]. The latter gave 80% inhibition of behavioral effects induced by substance P at 10 mg/kg s.c. I drug formulations were prepared The experimental process involved the reaction of (S)-2-(2-Methoxyphenyl)propanoic acid(cas: 81616-80-0).Application In Synthesis of (S)-2-(2-Methoxyphenyl)propanoic acid

The Article related to isoindolone acyldiphenylperhydro substance p antagonist, analgesic acyldiphenylperhydroisoindolone preparation, antiinflammatory acyldiphenylperhydroisoindolone preparation, antiallergic acyldiphenylperhydroisoindolone preparation, nervous system agent acyldiphenylperhydroisoindolone preparation and other aspects.Application In Synthesis of (S)-2-(2-Methoxyphenyl)propanoic acid

Referemce:
Ether – Wikipedia,
Ether | (C2H5)2O – PubChem

On October 12, 2006, Connolly, Stephen; Skrinjar, Marco published a patent.Reference of 3-(2-Methoxyphenoxy)benzaldehyde The title of the patent was Preparation of novel diazaspiroalkanes and their use for treatment of CCR8 mediated diseases. And the patent contained the following:

The title compounds I [R = pyridine N-oxide; R1 = II, III; R3 = OMe, OEt; R4 = H, OMe, OEt], useful in treating CCR8 mediated diseases such as asthma, COPD and rhinitis, were prepared E.g., a multi-step synthesis of IV, starting from tert-Bu 3,9-diazaspiro[5.5]undecane-3-carboxylate hydrochloride and 3-phenoxybenzaldehyde, was given. IV showed IC50 of 2.67 μM against human recombinant chemokine CCR8 receptor binding. Pharmaceutical compositions containing compounds I and their use in therapy are disclosed. The experimental process involved the reaction of 3-(2-Methoxyphenoxy)benzaldehyde(cas: 66855-92-3).Reference of 3-(2-Methoxyphenoxy)benzaldehyde

The Article related to diazaspiroalkane diazaspiroundecane preparation chemokine ccr8 mediated disease treatment, antiasthmatic diazaspiroalkane diazaspiroundecane preparation, chronic obstructive pulmonary disease diazaspiroalkane diazaspiroundecane preparation, rhinitis diazaspiroalkane diazaspiroundecane preparation and other aspects.Reference of 3-(2-Methoxyphenoxy)benzaldehyde

Referemce:
Ether – Wikipedia,
Ether | (C2H5)2O – PubChem

On October 12, 2006, Connolly, Stephen; Skrinjar, Marco published a patent.Quality Control of 3-(2-Methoxyphenoxy)benzaldehyde The title of the patent was Preparation of novel diazaspiroalkanes and their use for treatment of CCR8 mediated diseases. And the patent contained the following:

The title compounds I [R = (un)substituted pyridin-2-one or N-alkyl pyridin-2-one; R1 = II, III; R3, R4 = OMe, OEt], useful in treating CCR8 mediated diseases such as asthma, COPD and rhinitis, were prepared E.g., a multi-step synthesis of IV, starting from tert-Bu 3,9-diazaspiro[5.5]undecane-3-carboxylate hydrochloride and 2-(2-methoxyphenoxy)benzaldehyde, was given. IV showed IC50 of 0.044 μM against human recombinant chemokine CCR8 receptor binding. Pharmaceutical compositions containing compounds I and their use in therapy are disclosed. The experimental process involved the reaction of 3-(2-Methoxyphenoxy)benzaldehyde(cas: 66855-92-3).Quality Control of 3-(2-Methoxyphenoxy)benzaldehyde

The Article related to diazaspiroalkane diazaspiroundecane preparation chemokine ccr8 mediated disease treatment, antiasthmatic diazaspiroalkane diazaspiroundecane preparation, chronic obstructive pulmonary disease diazaspiroalkane diazaspiroundecane preparation, rhinitis diazaspiroalkane diazaspiroundecane preparation and other aspects.Quality Control of 3-(2-Methoxyphenoxy)benzaldehyde

Referemce:
Ether – Wikipedia,
Ether | (C2H5)2O – PubChem